1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-acquired Infection Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Instrument and Reagents
1.2.3 Consumables
1.3 Market by Application
1.3.1 Global Hospital-acquired Infection Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Ambulatory Surgery Centers (ASC)
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hospital-acquired Infection Diagnostics Market Perspective (2017-2028)
2.2 Hospital-acquired Infection Diagnostics Growth Trends by Region
2.2.1 Hospital-acquired Infection Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Hospital-acquired Infection Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Hospital-acquired Infection Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Hospital-acquired Infection Diagnostics Market Dynamics
2.3.1 Hospital-acquired Infection Diagnostics Industry Trends
2.3.2 Hospital-acquired Infection Diagnostics Market Drivers
2.3.3 Hospital-acquired Infection Diagnostics Market Challenges
2.3.4 Hospital-acquired Infection Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital-acquired Infection Diagnostics Players by Revenue
3.1.1 Global Top Hospital-acquired Infection Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital-acquired Infection Diagnostics Revenue
3.4 Global Hospital-acquired Infection Diagnostics Market Concentration Ratio
3.4.1 Global Hospital-acquired Infection Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-acquired Infection Diagnostics Revenue in 2021
3.5 Hospital-acquired Infection Diagnostics Key Players Head office and Area Served
3.6 Key Players Hospital-acquired Infection Diagnostics Product Solution and Service
3.7 Date of Enter into Hospital-acquired Infection Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-acquired Infection Diagnostics Breakdown Data by Type
4.1 Global Hospital-acquired Infection Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Type (2023-2028)
5 Hospital-acquired Infection Diagnostics Breakdown Data by Application
5.1 Global Hospital-acquired Infection Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Hospital-acquired Infection Diagnostics Market Size (2017-2028)
6.2 North America Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022)
6.3 North America Hospital-acquired Infection Diagnostics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Hospital-acquired Infection Diagnostics Market Size (2017-2028)
7.2 Europe Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022)
7.3 Europe Hospital-acquired Infection Diagnostics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022)
8.3 Asia-Pacific Hospital-acquired Infection Diagnostics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Hospital-acquired Infection Diagnostics Market Size (2017-2028)
9.2 Latin America Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022)
9.3 Latin America Hospital-acquired Infection Diagnostics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022)
10.3 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
11.1.5 Abbott Laboratories Recent Development
11.2 Advan DX
11.2.1 Advan DX Company Detail
11.2.2 Advan DX Business Overview
11.2.3 Advan DX Hospital-acquired Infection Diagnostics Introduction
11.2.4 Advan DX Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
11.2.5 Advan DX Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Hospital-acquired Infection Diagnostics Introduction
11.3.4 Abbott Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
11.3.5 Abbott Recent Development
11.4 Astrazeneca PLC
11.4.1 Astrazeneca PLC Company Detail
11.4.2 Astrazeneca PLC Business Overview
11.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Introduction
11.4.4 Astrazeneca PLC Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
11.4.5 Astrazeneca PLC Recent Development
11.5 Bayer Schering Pharma LLC
11.5.1 Bayer Schering Pharma LLC Company Detail
11.5.2 Bayer Schering Pharma LLC Business Overview
11.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Introduction
11.5.4 Bayer Schering Pharma LLC Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
11.5.5 Bayer Schering Pharma LLC Recent Development
11.6 Becton Dickinson And Company
11.6.1 Becton Dickinson And Company Company Detail
11.6.2 Becton Dickinson And Company Business Overview
11.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Introduction
11.6.4 Becton Dickinson And Company Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
11.6.5 Becton Dickinson And Company Recent Development
11.7 Cepheid Inc.
11.7.1 Cepheid Inc. Company Detail
11.7.2 Cepheid Inc. Business Overview
11.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Introduction
11.7.4 Cepheid Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
11.7.5 Cepheid Inc. Recent Development
11.8 Roche AG
11.8.1 Roche AG Company Detail
11.8.2 Roche AG Business Overview
11.8.3 Roche AG Hospital-acquired Infection Diagnostics Introduction
11.8.4 Roche AG Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
11.8.5 Roche AG Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Detail
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Introduction
11.9.4 Daiichi Sankyo Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
11.9.5 Daiichi Sankyo Recent Development
11.10 Hologic, Inc.
11.10.1 Hologic, Inc. Company Detail
11.10.2 Hologic, Inc. Business Overview
11.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Introduction
11.10.4 Hologic, Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2017-2022)
11.10.5 Hologic, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
